View Information Collection Request (ICR) Package

OMB Control No: 0920-1296	ICR Reference No: 202007-0920-015
Status: Historical Active	Previous ICR Reference No: 202004-0920-012
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-1296-20QW
Title: Emerging Infections Program Tracking of SARS-CoV-2 Infections among Healthcare Personnel
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR: No
Type of Review Request: Emergency	Approval Requested By: 04/28/2020
OIRA Conclusion Action: Approved with change	Conclusion Date: 07/27/2020
	Date Received in OIRA: 07/24/2020
Terms of Clearance: Previous terms continue: Approved consistent with the understanding that all discussions and publications will clearly describe the limitations of the data, including its limited generalizability.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	10/31/2020	10/31/2020	10/31/2020
Responses	5,620	0	5,320
Time Burden (Hours)	2,543	0	2,310
Cost Burden (Dollars)	0	0	0

Abstract: The goal of this information collection is to inform guidance for healthcare facilities to protect the healthcare workforce from the effects of COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. The healthcare workforce is a critical asset during this pandemic. Protecting healthcare personnel (HCP) is an essential component of protecting patients.The data collected from this project will be used to inform guidance for healthcare facilities to protect HCP. The Change Request involves minor modifications to the previously-approved instruments. These changes include: 1) additional response choices to questions about COVID-19 signs/symptoms, HCP’s roles, areas of facility(ies) in which they work and where close contact with COVID-19 patient(s) occurred; 2) new or modified questions regarding the use of teleworking during timeframe of interest, contact with person(s) with COVID-19 who were not patients in healthcare facility(ies), the reuse and extended use of N95 respirators, the use of alternative or improvised equipment during care of COVID-19 patients, and flu vaccination; 3) modified denominator data collection form; 4) addition of an abbreviated form to capture HCP with a potential reinfection.

Emergency Justfication: The CDC, in collaboration with Emerging Infections Program (EIP) sites, plans to implement a system to track and assess risk factors for SARS-CoV-2 infections among HCP. The objectives are to: 1) determine the extent of COVID-19 among HCP working in U.S. healthcare facilities; 2) describe characteristics of HCP exposed to or infected with SARS-CoV-2, including clinical activities and personal protective equipment use; and 3) compare exposures and other characteristics of HCP cases and exposed HCP that do not become cases to identify risk factors or protective factors for COVID-19. The information must be collected as soon as possible and this information is essential to CDC’s and state and local health departments’ ability, as well as that of healthcare facilities, to effectively address the national public health crisis caused by the novel coronavirus SARS-CoV-2 (COVID-19). As rates of infection and resulting hospitalizations continue to rise across the nation, healthcare personnel (HCP) are facing significant risk of contracting SARS-CoV-2 during their interactions with patients with suspected or confirmed COVID-19 or patients with unrecognized infection. Understanding the factors that place HCP at greater risk for infection as well as factors that may reduce risk is critical to the nation’s effective pandemic response. The U.S. healthcare workforce is among our most vital assets, and protecting our workforce also protects patients. CDC cannot reasonably comply with the normal clearance procedures due to the public harm that could escalate if routine processing of this request is required. CDC requests authorization to use a previously OMB-approved form (OMB Control No. 0920-1011, expiration date 04/23/2020) with minor modifications for 180 days to enable CDC and EIP sites to proceed immediately with tracking and interviewing of HCP infected with or exposed to SARS-CoV-2. Absent this emergency approval, CDC will not be able to implement Emerging Infections Program Tracking of SARS-CoV-2 Infections among Healthcare Personnel with the urgency that is required.

Authorizing Statute(s): US Code: 42 USC 241 Name of Law: US Public Health Service Act

Citations for New Statutory Requirements: None

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

Federal Register Notices & Comments
Did the Agency receive public comments on this ICR? No

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Agency Discretion
Annual Number of Responses	5,620	5,320	300
Annual Time Burden (Hours)	2,543	2,310	233
Annual Cost Burden (Dollars)	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: Changes to Assessment of Healthcare Personnel Exposed to or Infected with SARS-CoV-2 Form or Assessment of Healthcare Personnel Exposed to or Infected with SARS-CoV-2: Possible Reinfection Form result in slight increase in burden.

Annual Cost to Federal Government: $5,527

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Yes

Agency Contact: Jeffrey Zirger 404 639-7118 wtj5@cdc.gov

View ICR - OIRA Conclusion